24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
13/12/2017
ALBA Synchrotron Works for People’s Health
01/12/2017
NanoPlastics Awarded As Best Business Idea Of The UAB University Research Park
23/11/2017
The Excellence of Natura Bissé Awarded by Forbes Travel Guide
08/11/2017
SENER, 50 Years in Space and Ambitious Projects Such As the E-ELT Telescope
02/11/2017
The Barcelona Synchrotron Park in the SmartReFlex European project
26/10/2017
New Findings on Malaria Thanks to ALBA Synchrotron